Effects of artemisinin-tagged holotransferrin on cancer cells

This publication has 33 references indexed in Scilit:

• Inhibitory Effects of Artesunate on Angiogenesis and on Expressions of Vascular Endothelial Growth Factor and VEGF Receptor KDR/flk-1
  Pharmacology, 2004
• Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
  Pharmacological Research, 2003
• Pharmacokinetics of Artemisinin-Type Compounds
  Clinical Pharmacokinetics, 2000
• NMR Studies on Novel Antitumor Drug Candidates, Deoxoartemisinin and Carboxypropyldeoxoartemisinin
  Biochemical and Biophysical Research Communications, 2000
• Stability of Artemisinin in Aqueous Environments: Impact on its Cytotoxic Action to Ehrlich Ascites Tumour Cells
  Journal of Pharmacy and Pharmacology, 1997
• Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria
  British Journal of Clinical Pharmacology, 1996
• Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin
  Cancer Letters, 1995
• Cytotoxicity of Artemisinin-Related Endoperoxides to Ehrlich Ascites Tumor Cells
  Journal of Natural Products, 1993
• Expression of glycosylated and nonglycosylated human transferrin in mammalian cells. Characterization of the recombinant proteins with comparison to three commercially available transferrins
  Biochemistry, 1993
• Structure determination of two oligomannoside-type glycopeptides obtained from bovine lactotransferrin, by 500 MHz 1H-NMR spectroscopy
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981